This invention relates to a stent delivery system to improve a stenosed part or occluded part in the lumen of a living body, such as a blood vessel, biliary duct, trachea, esophagus, and urethra.
A stent delivery system is used to deliver a stent to improve certain legions (such as a stenosis or occlusion) occurring in the lumen of a living body. A stent is, in general, a tubular medical device for treating any of a variety of diseases caused by stenosis or occlusion of a blood vessel or other living body lumen. The stent is put indwelling in the stenosed or obliterated part of the lumen in order to dilate the stenosis or occlusion and thereby enlarge the inner cavity through the lumen.
The following description is made below by reference to a blood vessel merely as a representative example of a lumen and is not restricted thereto.
A stent is a body for insertion into a living body from the exterior. The stent is small in diameter at the time of insertion, and is expanded in a target stenosed or occluded part so as to enlarge in diameter and maintain the lumen at that state.
In general, a stent is a hollow cylindrical member obtained by processing metallic wires or a metallic pipe. The stent is mounted to a catheter or the like in a radially reduced state, is inserted into a living body, and is then expanded in a target part by some method such that it is in secure contact with and fixed on the internal wall of the lumen at the target part, thereby maintaining the lumen shape. Stents are classified, according to the function and the method of placement, into self-expandable stents and balloon-expandable stents. A balloon-expandable stent is a stent which itself does not have an expanding function, and is used in such a manner that the stent mounted on a balloon is inserted into a target part, and thereafter the balloon is dilated to expand (elastically deform) the stent by the dilation force of the balloon, whereby the stent is put into secure contact with and fixed on the internal surface of the lumen at the target part. This type of stent needs the force of the balloon to expand the stent. On the other hand, a self-expandable stent is a stent which itself is provided with an expanding function, and is used in such a manner that the stent is inserted into a living body in a radially contracted state, and is relieved from the contracted state in a target part, whereby the stent is allowed to expand by itself into its original expanded state so as to be put into secure contact with and fixed on the internal surface of the lumen, thereby maintaining the lumen shape.
The purpose of stent placement at present is for returning a blood vessel that has been stenosed for some reason into its original patent state. Thus, most of the stents are used mainly for preventing or restraining restenosis which might otherwise occur after such a surgical procedure as percutaneous transluminal coronary angioplasty (PTCA). In recent years, for further suppression of the probability of restenosis, drug-eluting stents with a drug such as an immunosuppressant or carcinostatic agent loaded thereon have been used, and their effect has been generally known.
Most of the self-expandable stents are used in peripheral, such as blood vessels in an inferior limb or carotid artery. An example of a self-expandable stent is disclosed in International Application Publication No. WO 96/26689 (JP-T-H11-505441).
In a further configuration described in International Application Publication No. WO 2004/091450 (JP-T-2006-522654), the stent delivery system includes a catheter which has an inner shaft, at least a part of the inner shaft forming a stent-mounting region, a stent which has stent struts and changes between a non-expanded state and an expanded state, the stent being disposed around at least a part of the stent-mounting region while in the non-expanded state, and at least one band which forms at least a part of the stent-mounting region, the band being provided with a main body region having an external surface and a plurality of projections extending radially outward from the external surface. When the stent is in the non-expanded state, at least a part of the stent is disposed around and engaged with at least a part of the main body region of the band, and each of the projections has entered a space formed between the stent struts.
In addition,
In the stent delivery system using the self-expandable stent as described in International Application Publication No. WO 96/26689, the self-expanding property possessed by the stent makes the positioning at the time of stent placement more difficult as compared with the case of a balloon-expandable stent. In addition, a jumping phenomenon in which the stent jumps out from the delivery system unexpectedly may occur. If this phenomenon occurs, the stent would be disposed at a position deviated from a planned disposing position. In the procedure of indwelling the stent, readjustment of the indwelling position may be needed to some extent after the stent is discharged. In the stent delivery system described in International Application Publication No. WO 96/26689, however, it is difficult to re-contain the stent into the stent delivery system so as to make further position adjustments.
In the stent delivery system described in International Application Publication No. WO 2004/091450, immediately upon exposure of a distal portion of the stent, the band on the distal side is spaced from the stent, so that only the band on the proximal side remains in engagement with the stent. When the sheath is pulled in this condition, all the frictional resistance between the stent and the sheath is loaded on the projections of the band on the proximal side, so that an excessive load is also exerted on the stent struts in engagement with the projections, which may result in breakage of the stent.
In addition, it has been found that when the projections have entered the spaces between the stent struts as in International Application Publication No. WO 2004/091450, the sheath may become caught on the projections and essentially be locked in position, thus making it difficult to further pull the sheath. Also in the system described in PCT Publication No. WO 2004/091450, it is necessary to align the spaces between the stent struts with the projections, which further increases the level of difficulty to re-contain the stent into the stent delivery sheath.
The stent delivery system disclosed herein includes a stent having a multiplicity of side wall openings, formed in a substantially hollow cylindrical shape, compressed toward a center axis thereof when inserted into a living body, and capable of being restored into a pre-compression shape by expanding outward when put indwelling in the living body; an inner tube body having a guide wire lumen; and a stent-containing tube body which contains the stent in a distal portion thereof, the stent being so disposed as to cover a distal portion of the inner tube body, and the stent being dischargeable by moving the stent-containing tube body toward a proximal side relative to the inner tube body. The inner tube body includes a distal contact section which is located in a proximal portion of the stent and which does not enter the side wall openings of the stent, and a proximal contact section which is disposed at a position rear of a proximal end of the stent and close to the distal contact section and which is capable of making contact with the proximal end of the stent; the stent is provided with a proximal inwardly protruding section capable of making contact with the distal contact section of the inner tube body. The stent is disposed so that the proximal inwardly protruding section is located between the distal contact section and the proximal contact section of the inner tube body; and the stent is provided with a distal portion and the proximal portion oriented respectively to a distal side and the proximal side of the stent-containing tube body and does not, except in the proximal portion thereof, have a bent free end which protrudes to the proximal side.
A stent delivery system will be described below by reference to the embodiments disclosed here as examples and as shown in the accompanying drawings.
Referring initially to
The inner tube body 3 includes a distal contact section 36 which is located within a proximal portion of the stent 10 and which does not enter the side wall openings of the stent 10; and a proximal contact section 35 which is disposed at a position rearward (proximal) of a proximal end of the stent 10 and close to the distal contact section 36 and which is capable of making contact with the proximal end of the stent 10. In addition, the stent 10 has a proximal inwardly protruding section 17a capable of making contact with the distal contact section 36 of the inner tube body 3. Further, the stent 10 is so disposed that the proximal inwardly protruding section 17a is located between the distal contact section 36 and the proximal contact section 35 of the inner tube body 3.
In the stent delivery system 1 in the embodiment shown in
In addition, the stent delivery system 1 according to this embodiment includes the stent 10 capable of being restored into a pre-compression shape by expanding outward when put indwelling in a living body; the stent-containing tube body (sheath) 2 which contains the stent 10 in a distal portion thereof; and the shaft section 3 which is slidably passed inside the stent-containing tube body (sheath) 2 and which is used for discharging the stent 10 from the distal end of the stent-containing tube body (sheath) 2. The stent 10 has a distal portion and a proximal portion oriented respectively to the distal side and the proximal side of the stent-containing tube body (sheath) 2. The stent 10 does not, except in the proximal portion, have a substantially bent free end protruding to the proximal side (or in other words, protruding in the proximal direction). That is, other than the proximal portion, the stent 10 does not include portions, extending toward the proximal end, which are both bent and unconnected to another portion (another strut) of the stent. The stent 10 is so configured that after a distal portion thereof is exposed from the stent-containing tube body (sheath) 2, the exposed portion can again be contained into the stent-containing tube body (sheath) 2 by moving the stent-containing tube body (sheath) 2 toward the distal side relative to the shaft section (inner tube body) 3. The stent delivery system 1 has the guide wire lumen 61 of which one end opens at the distal end of the stent delivery system and the other end opens on the proximal side relative to the stent-containing part of the sheath 2.
The stent delivery system 1 as thus disclosed includes the stent 10, the sheath (stent-containing tube body) 2 which contains the stent 10 in a distal portion thereof, and the shaft section (inner tube body) 3 which is slidably passed inside the sheath 2.
As shown in
The sheath tube 21 is a tubular body with openings at the distal end and the proximal end thereof. The distal opening functions as a port through which the stent 10 is discharged when putting the stent 10 indwelling in a lesion part in a body cavity. By being discharged via the distal opening, the stress load on stent 10 is relieved, and the stent 10 expands and is restored into its pre-compression shape. A distal portion of the sheath tube 21 forms the stent-containing part 21a which contains the stent 10 inside the sheath tube 21. In addition, the sheath tube 21 has a side hole 23 provided on the proximal side relative to the stent-containing part 21a. The side hole 23 is for leading out a guide wire outward therethrough to an exterior of the sheath tube 21.
In addition, a radiopaque marker 28 is preferably provided at the distal portion of the sheath (stent-containing tube body) 2. As shown in
The outside diameter of the sheath tube 21 is preferably 0.5 to 4.0 mm, particularly preferably 0.8 to 2.0 mm. The inside diameter of the sheath tube 21 is preferably 0.2 to 1.8 mm, and the length of the sheath tube 21 is preferably 300 to 2500 mm, particularly preferably 300 to 2000 mm.
Taking the properties required of the sheath tube into account, such as flexibility, hardness, strength, slidability, anti-kinking properties, stretchability, examples of the material which can be suitably used to form the sheath tube 21 include polyolefins such as polyethylene and polypropylene; nylon; polyethylene terephthalate; fluoro-polymers such as PTFE and ETFE; and thermoplastic elastomers. The thermoplastic elastomers are most suitably selected from among nylon-based ones (e.g., polyamide elastomer), urethane-based ones (e.g., polyurethane elastomer), polyester-based ones (e.g., polyethylene terephthalate elastomer), and olefin-based ones (e.g., polyethylene elastomer, polypropylene elastomer).
Furthermore, the external surface of the sheath 2 is preferably subjected to a treatment for enhancing the lubricity of the surface. Examples of such a treatment include a method in which the external surface is coated with a hydrophilic polymer such as poly(2-hydroxyethyl methacrylate), polyhydroxyethyl acrylate, hydroxypropyl cellulose, methyl vinyl ether-maleic anhydride copolymer, polyethylene glycol, polyacrylamide, polyvinylpyrrolidone, or dimethylacrylamide-glycidyl methacrylate copolymer, and a method in which such a hydrophilic polymer is fixed to the external surface. In addition, the internal surface of the sheath tube 21 may be coated with such a hydrophilic polymer or the hydrophilic polymer may be fixed to the internal surface, to provide good slidability of the internal surface relative to the stent 10 and the shaft section 3.
The sheath hub 22 is fixed to a proximal portion of the sheath tube 21, as shown in
The sheath hub 22 is preferably made from a hard or semi-hard material. Examples of such a hard or semi-hard material include synthetic resins such as polycarbonate, polyolefins (e.g., polyethylene, polypropylene, ethylene-propylene copolymer), styrene-based resins [e.g., polystyrene, MS resin (methacrylate-styrene copolymer), MBS resin (methacrylate-butylene-styrene copolymer)], and polyesters; and metals such as stainless steel, aluminum, and aluminum alloys.
Elastic materials are preferably used to form the seal member 25 and an elastic ring 69, which are described in greater detail below. Examples of such elastic materials include rubbers such as synthetic rubbers, e.g., urethane rubber, silicone rubber, or butadiene rubber, and natural rubbers, e.g., latex rubber; and synthetic resin elastomers such as olefin-based elastomers (e.g., polyethylene elastomer, polypropylene elastomer), polyamide elastomers, styrene-based elastomers (e.g., styrene-butadiene-styrene copolymer, styrene-isoprene-styrene copolymer, styrene-ethylenebutylene-styrene copolymer), polyurethane, urethane-based elastomers, and fluoro-resin elastomers.
In addition, at the distal portion of the sheath hub 22 are provided reinforcement members 26 and 27 which extend toward the distal side beyond the distal end of the sheath hub.
As shown in
In this embodiment, the shaft section 3 is provided with a guide wire lumen proximal opening 62 which opens at a side portion on the proximal side relative to the stent-containing part of the sheath 2, and the sheath 2 is provided with a sheath side hole 23 on the proximal side relative to the stent-containing part, in such a manner that a guide wire can be inserted and passed via the sheath side hole and the proximal opening.
As shown in
The stent 10 to be used in the stent delivery system 1 is a so-called self-expandable stent which has a multiplicity of openings in the side surface thereof and which can be restored into a pre-compression shape by expanding outward when put indwelling in a living body. Further, the stent 10 has a configuration in which the stent 10 has a distal portion and a proximal portion oriented respectively to the distal side and the proximal side of the sheath 2. The stent 10 does not, except in the proximal portion, have a bent free end protruding to the proximal side (in other words, a free end that is bent and oriented toward the proximal side). That is, other than the proximal portion, the stent 10 does not include portions, extending toward the proximal end, which are both bent and unconnected to another portion (another strut) of the stent. The stent 10 is so configured that after a distal portion thereof is exposed from the sheath 2, the exposed distal portion can again be contained into the sheath 2 by moving the sheath 2 toward the distal side relative to the shaft section 3.
The stent to be used may be a stent which does not have a free end, owing to a structure in which a vertex of a proximal bent section or a portion near the vertex is connected to other linear component element. Besides, the stent to be used may be as shown in
The stent 10 includes wavy struts 13, 14 extending in the axial direction from one end to the other end of the stent and being arrayed in plurality along the circumferential direction of the stent, with one or a plurality of connection struts 15 interconnecting each pair of adjacent wavy struts and extending over a predetermined length in the axial direction. The end portions of the wavy struts 13, 14 are each connected to an end portion of an adjacent wavy strut. In addition, the stent 10 is provided with a multiplicity of openings formed between the struts.
Particularly, the stent 10 shown in
The stent 10 of this example is a so-called self-expandable stent having a substantially hollow cylindrical shape, compressed toward its center axis when inserted into a living body and being restored into its pre-compression shape by expanding outward when put indwelling in the living body.
The first wavy struts 13 extend in an axial direction substantially in parallel to the center axis of the stent. The first wavy struts 13 are arrayed in plurality in the circumferential direction of the stent. The number of the first wavy struts 13 is preferably not less than three, and more particularly, preferably three to eight. Furthermore, the plurality of first wavy struts 13 is preferably disposed at substantially regular angular intervals around the center axis of the stent (not shown).
The second wavy struts 14 also extend in an axial direction substantially in parallel to the center axis of the stent. The second wavy struts 14 are arrayed in plurality in the circumferential direction of the stent, and each of the second wavy struts 14 is disposed between the first wavy struts. The number of the second wavy struts 14 is preferably not less than three, and more particularly, preferably three to eight. Furthermore, the plurality of second wavy struts is preferably disposed at substantially regular angular intervals around the center axis of the stent. In addition, the number of the second wavy struts 14 is the same as the number of the first wavy struts 13.
This embodiment of stent 10 has one or a plurality of connection struts 15 interconnecting each pair of the first wavy strut 13 and the second wavy strut 14 adjacent to each other and extending over a predetermined length in the axial direction. Especially, in the stent 10 in this example, the connection strut 15 has its one end in the vicinity of an inflection point of the wavy strut on one side, has its other end in a region ranging from the vicinity of a vertex to a point located a little beyond the vertex of the adjacent wavy strut on the other side, extends in the axial direction, and is bent to the same direction as the vertex of the wavy strut on the other side. Specifically, as shown in
The stent 10 in this example has coupling sections 16, 18 which respectively couple the end portion of a first wavy strut on one side and the end portion of the first wavy strut on the other side with an end portion of one of the second wavy struts adjacent thereto. Specifically, an end portion 13a on the one side (i.e., the proximal side) of the first wavy strut of the stent 10 is coupled by the coupling section 16 to an end portion 14a on the one side (i.e., the proximal side) of the adjacent second wavy strut 14 located circumferentially on one side of the first wavy strut 13 (specifically, the second wavy strut 14 adjacent to the first wavy strut and located on one side thereof in the circumferential direction). Meanwhile, an end portion 13b on the other side (i.e., the distal side) of the first wavy strut is coupled by the coupling section 18 to an end portion 14b on the other side (i.e., the distal side) of the adjacent second wavy strut 14 located circumferentially on the other side of the first wavy strut 13 (specifically, the second wavy strut 14 adjacent to the first wavy strut and located on the other side thereof in the circumferential direction). In other words, the coupling section 16 on the one end and the coupling section 18 on the other end each couple a different pair of a first wavy strut 13 and a second wavy strut 14 (the combination shifts by one line).
In addition, as shown in
As shown in
In the stent in the example of
The radiopaque marker 17 forming the proximal inwardly protruding section preferably has a predetermined thickness (wire diameter). Besides, in the structure shown in
Incidentally, the proximal portion (coupling section) of the stent may, as shown in
Furthermore, the proximal portion (coupling section) of the stent may not have the above-mentioned opening 43, as shown in
In the stent in this example, a coupling section 45 is a slightly curved plate-shaped section with a predetermined area, and the radiopaque marker 17 is so mounted as to cover the face and back sides of the coupling section 45. Further, in the stent in this example, the proximal inwardly protruding section 17a of the stent 10 is formed of that portion of the sheet-shaped member wound around the proximal portion (coupling section) 45 of the stent 10 which is on the inner side of the stent. Furthermore, in the stent in this example, the sheet-shaped member has an inner overlap section 17b which protrudes to the inner side of the stent 10, thereby forming a section protruding more than the other section.
As in the examples shown in
Incidentally, in all the examples mentioned above, it is preferable to use the above-mentioned sheet-shaped member as the radiopaque marker, however, one formed by winding a wire-shaped member around the proximal portion (coupling section) of the stent may also be used. In this case as well, the radiopaque marker is preferably provided with an inner overlap section which protrudes to the inner side of the stent. The above-mentioned radiopaque marker can suitably be made of one (simple substance) or at least two (alloy) materials selected from the group consisting of iridium, platinum, gold, rhenium, tungsten, palladium, rhodium, tantalum, silver, ruthenium, and hafnium.
Fixation of the radiopaque marker can be carried out by means of any of welding, soldering, adhesion, fusing, and diffusion, or any other known method of fixing.
The material constituting the stent 10 is preferably a superelastic metal, and more preferably, the superelastic metal is a superelastic alloy. Superelastic alloys, as used here, mean those alloys which are generally called shape memory alloys and which show superelasticity at least at a living body temperature (around 37□C). Particularly, such superelastic alloys as Ti—Ni alloys containing 49 to 53 atomic % of Ni, Cu—Zn alloys containing 38.5 to 41.5 wt. % of Zn, Cu—Zn—X alloys (X=Be, Si, Sn, Al, Ga) containing 1 to 10 wt. % of X, and Ni—Al alloys containing 36 to 38 atomic % of Al are preferably used. Especially preferred are the above Ti—Ni alloys. Besides, mechanical properties of the superelastic alloys can be changed, as required, by replacing part of the Ti—Ni alloys with 0.01 to 10.0% of X to obtain Ti—Ni—X alloys (X=Co, Fe, Mn, Cr, V, Al, Nb, W, B or the like), by replacing part of the Ti—Ni alloys with 0.01 to 30.0% of X to obtain Ti—Ni—X alloys (X=Cu, Pb, Zr), or by selecting a cold working rate and/or final heat treatment conditions. Further, by selecting the cold working rate and/or final heat treatment conditions while using the Ti—Ni—X alloys, it is possible to change the mechanical properties of the alloys as required. The buckling strength (yield stress when loaded) of the superelastic alloy used is preferably 5 to 200 kg/mm2 (22□C), more preferably 8 to 150 kg/mm2, and the restoring stress (yield strength when unloaded) of the superelastic alloys is preferably 3 to 180 kg/mm2 (22□C), more preferably 5 to 130 kg/mm2. The superelasticity here means a property of a material such that even when the material is deformed (bent, stretched or compressed) into a region in which ordinary metals are plastically deformed at a use temperature, the deformed material is restored substantially into the pre-compression shape after the deformation is released, without need for heating.
The diameter of the stent when compressed is preferably 0.5 to 1.8 mm, and more particularly, preferably 0.6 to 1.4 mm. The length of the stent when non-compressed is preferably 5 to 200 mm, and more particularly, preferably 8.0 to 100.0 mm. The diameter of the stent when non-compressed is preferably 1.5 to 6.0 mm, and more particularly, preferably 2.0 to 5.0 mm. Further, the wall thickness of the stent is preferably 0.05 to 0.15 mm, and more particularly, preferably 0.05 to 0.40 mm. The width of the wavy struts is preferably 0.01 to 1.00 mm, and more particularly, preferably 0.05 to 0.2 mm. The surfaces of the wavy struts are preferably smooth surfaces obtained by processing, more preferably surfaces smoothened by electrolytic polishing. In addition, the radial-directional strength of the stent is preferably 0.1 to 30.0 N/cm, and more particularly, preferably 0.5 to 5.0 N/cm.
As shown in
The proximal inwardly protruding section 17a of the stent 10 as mentioned above is capable of making contact with the distal contact section 36 of the inner tube body 3. In addition, as shown in
As shown in
The distal contact section 36 does not enter the side wall openings of the stent 10. Furthermore, the distal contact section 36, preferably, does not substantially make contact with the internal surface of the stent 10. In addition, the distal contact section 36 is preferably an annular protruding section provided continuously over the outer circumference of the distal tube 31. The annular protruding section is formed, for example, by attaching a tubular member to the outer circumference of the distal tube. With the distal contact section 36 set to be such an annular protruding section, its contact with the proximal inwardly protruding section 17a of the stent 10 becomes assured. Besides, the distal contact section 36, preferably, does not substantially make contact with the internal surface of the stent 10. This ensures that the distal contact section 36 would not become an obstacle at the time of discharging the stent. The distal contact section 36 has such a height as to be able to make contact with the proximal inwardly protruding section 17a of the stent 10. The height of the distal contact section 36 is preferably 0.06 to 0.11 mm, and more particularly, preferably 0.08 to 1.1 mm. In addition, the axial length of the distal contact section 36 is preferably 0.1 to 3.0 mm, and more particularly, preferably 0.3 to 2.0 mm.
Incidentally, while the distal contact section 36 is preferably an annular protruding section provided continuously over the outer circumference of the distal tube 31, it may be a plurality of non-continuous ribs which are arranged in an annular pattern.
Further, the proximal contact section 35 is also preferably an annular protruding section provided continuously over the outer circumference of the distal tube 31. The annular protruding section is formed, for example, by attaching a tubular member to the outer circumference of the distal tube. In addition, the proximal contact section 35, preferably, does not make contact with the internal surface of the sheath 2. This ensures that the proximal contact section 35 would not become an obstacle at the time of discharging the stent. The proximal contact section 35 has such a height as to be able to make contact with the proximal end of the stent 10. The height of the proximal contact section 35 is preferably 0.08 to 0.18 mm, and more particularly, preferably 0.1 to 0.16 mm. The axial length of the proximal contact section 35 is preferably 0.1 to 3.0 mm, and more particularly, preferably 0.3 to 2.0 mm. The distance between the proximal contact section 35 and the internal surface of the sheath is preferably 0.01 to 0.04 mm. Preferably, the proximal contact section 35 is higher than the distal contact section 36, with the difference in height between them being 0.02 to 0.1 mm.
Furthermore, the distal contact section 36 and the proximal contact section 35 are preferably made from a radiopaque material. Any of the materials mentioned above for forming the radiopaque marker can be used for the distal contact section 36 and the proximal section 35. Particularly, these contact sections are each preferably formed by attaching a radiopaque tubular member. Furthermore, the distal contact section 36 and the proximal contact section 35, preferably, are each made from a radiopaque material and are different from each other in axial length. This enables easy discrimination between the two contact sections. While either of the two contact sections may be longer, the difference in length between them is preferably 0.3 to 1.0 mm.
In the stent delivery system 1 in this embodiment, the inner tube body 3 (specifically, the distal tube 31) has an opening 62 through which a guide wire is led out to the exterior on the proximal side relative to the stent-containing part of the stent-containing tube body 2.
In addition, the distal tube 31 is preferably provided with a reinforcement layer 31a at least at a part located on the proximal side relative to the proximal portion of the stent. In the structure of this embodiment, the reinforcement layer 31a is provided over the whole part of the distal tube 31. Incidentally, the reinforcement layer 31a may not be provided at a distalmost part of the distal tube 31. The reinforcement layer 31a is preferably a net-formed reinforcement layer. The net-formed reinforcement layer is preferably formed through the use of braid wires. The braid wires are, for example, wire braid, which can be formed from metallic wires of stainless steel, an elastic metal, a superelastic alloy, a shape memory alloy or the like having a wire diameter of 0.01 to 0.2 mm, preferably 0.03 to 0.1 mm. Besides, the net-formed reinforcement layer may be formed from synthetic fibers such as polyamide fibers, polyester fibers, and polypropylene fibers.
The shaft main body 33 includes a distal portion which is fixed to a proximal portion of the distal tube 31 at a distal portion thereof, a main body section extending over a predetermined length toward the proximal side, and a proximal portion protruding beyond the shaft hub 30. In this embodiment, the shaft main body 33 has a structure wherein the distal portion fixed to the distal tube 31 is a small-diameter portion, whereas the main body section and the proximal portion are greater in outside diameter than the small-diameter portion. Besides, in this embodiment, the distal portion of the shaft body 33 is fixed to a side surface of the distal tube 31 by a heat-shrinkable tube 63.
The length of the shaft section 3 is preferably 400 to 2500 mm, and more particularly, preferably 400 to 2200 mm. The outside diameter of the main body section of the shaft main body 33 is preferably 1.0 to 2.5 mm, and more particularly, preferably 1.0 to 2.0 mm. The length of the distal tube 31 is preferably 10 to 400 mm, and more particularly, preferably 50 to 350 mm, and the outside diameter of the distal tube 31 is preferably 0.2 to 2.0 mm, and more particularly, preferably 0.4 to 1.7 mm. The inside diameter of the lumen 61 is preferably 0.1 to 1.8 mm, and more particularly, preferably 0.3 to 1.0 mm.
The shaft main body 33 may be a solid body or a hollow tubular body. Besides, the shaft main body 33 may be a coil shaft. The material forming the shaft body 3 is preferably a material which is hard and is flexible to a certain extent. Examples of the material which can be suitably used include stainless steel, superelastic metals, polyolefins such as polyethylene and polypropylene, nylon, polyethylene terephthalate, fluoro-polymers such as ETFE, PEEK (polyether ether ketone), and polyimides. Incidentally, the external surface of the shaft section 3 may be coated with a biocompatible material, particularly an antithrombogenic material. Examples of the antithrombogenic material which can be suitably used include polyhydroxyethyl methacrylate and hydroxyethyl methacrylate-styrene copolymers (e.g., HEMA-St-HEMA block copolymer).
Furthermore, the external surface of that part of the shaft section 3 which may protrude beyond the sheath 2 preferably has lubricity. Therefore, the external surface of that part may be coated with a hydrophilic material such as poly(2-hydroxyethyl methacrylate), polyhydroxyethyl acrylate, hydroxypropyl cellulose, methyl vinyl ether-maleic anhydride copolymer, polyethylene glycol, polyacrylamide, polyvinylpyrrolidone, and dimethylacrylamide-glycidyl methacrylate copolymer, or may have such a hydrophilic material fixed thereto. In addition, the above-mentioned hydrophilic material may be applied or fixed to the whole part of the external surface of the shaft section 3. Further, the internal surface of the shaft section may also be coated with the above-mentioned hydrophilic material or may have the hydrophilic material fixed thereto, for enhancing slidability of the internal surface relative to a guide wire.
The shaft main body 33 passes through the sheath 2, to protrude beyond the proximal opening of the sheath 2. As shown in
The distal contact section and the proximal contact section in the stent delivery system according to one embodiment of the disclosure is shown in
Alternatively, the distal contact section and the proximal contact section in the stent delivery system according to a further embodiment are shown in
Alternatively, the distal contact section in the stent delivery system according to a still further embodiment is shown in
Further, the proximal contact section in the stent delivery system according to a further embodiment may be as shown in
Still further, in the stent delivery system according to the embodiment shown in
A further embodiment of the distal contact section and/or the proximal contact section in the stent delivery system is shown in
In all the embodiments described above, the tubular members having the opened-ring portions, the short semi-tubular members and the plurality of curved protrusions arranged in an annular pattern are each preferably made from a radiopaque material, and any of the materials described above for forming the radiopaque marker can also be used for forming the same.
The inner tube body 3a in this embodiment is substantially the same in configuration as the above-described inner tube body 3, except for the difference in the form of the distal portion of the shaft main body 33, as shown in
As shown in
The shaft main body 33 formed of the wire member includes a main body section of which distal side is fixed to a proximal portion of the distal tube 31 and extending over a predetermined length to the proximal side, and a proximal portion protruding beyond the shaft hub. In this embodiment, the shaft main body 33 extends to the vicinity of the proximal end of the stent 10 beyond the part fixed to the distal tube 31, and a distalmost end 33a of the shaft main body 33 forms the proximal contact section for making contact with the proximal end of the stent 10. The distalmost end 33a of the shaft main body 33 is preferably a curved distal portion having a predetermined circumferential width. This promises assured contact with the proximal portion 16 of the stent. Furthermore, the distalmost end of the shaft main body 33 may be an annular section 33b, as in the inner tube 3b shown in
The inner tube body 3c in this embodiment is substantially the same in configuration as the above-described inner tube body 3, except for the difference in the form of the distal tube 31 at the vicinity of the proximal portion of the stent 10.
As shown in
Specifically, as shown in
As shown in
Now, referring to
The stent delivery system 1 with the guide wire 65 inserted and passed in the distal tube 31 is inserted into a blood vessel to be treated, to bring a stent to an indwelling site. In this state, the whole part of the stent 10 is in the state of being contained in the sheath 2. Then, the sheath 2 is slid toward the proximal side, whereby the stent 10 is exposed from the distal opening of the sheath 2, as shown in
In addition, a further embodiment of the stent to be used in the stent delivery system may be as shown in
This stent 70 is a stent for indwelling in a living body that is formed in a substantially hollow cylindrical shape. The stent 70 includes wavy struts 73 and 74 which extend in the axial direction from one end to the other end of the stent 70 and which are arranged in plurality in the circumferential direction of the stent, and with a plurality of connection struts 75 interconnecting each pair of wavy struts 73 and 74 adjacent to each other. The adjacent wavy struts 73 and 74 have a plurality of closed sections and open sections. The connection struts 75 interconnect the closed sections of the adjacent wavy struts 73 and 74, and are each provided with, at its central portion, a bent section 85 extending toward the distal side in the axial direction of the stent.
Particularly, in this stent 70, the wavy struts 73 and 74 include a plurality of first wavy struts 73 having a plurality of upper points 73a and a plurality of lower points 73b, and a plurality of second wavy struts 74 having a plurality of upper points 74a and a plurality of lower points 74b, each being located between the first wavy struts. Each pair of the first wavy strut 73 and the second wavy strut 74 adjacent to each other are so disposed that the upper or lower points of the wavy strut on one side and the lower or upper points of the adjacent wavy strut on the other side substantially face each other, thereby forming the close sections. Each of the connection struts 75 interconnects the upper point 73a or lower point 73b of the first wavy strut 73 and the lower point 74b or upper point 74a of the second wavy strut which constitute a close section. In addition, the first wavy strut 73 and the second wavy strut 74 adjacent to each other are so disposed that the lower or upper points of the wavy strut on one side and the upper or lower points of the adjacent wavy strut on the other side are substantially opposite to each other, thereby forming the open sections.
This stent 70 is a so-called self-expandable stent which is formed in a substantially hollow cylindrical shape, is compressed toward a center axis thereof when inserted into a living body, and is restored into its pre-compression shape by expanding outward when put indwelling in the living body.
The first wavy struts 73 extend in an axial direction substantially parallel to the center axis of the stent. The first wavy struts 73 are arrayed in plurality in the circumferential direction of the stent. The number of the first wavy struts 73 is preferably not less than two, and more particularly, preferably three to eight. Furthermore, the plurality of first wavy struts 73 are preferably arranged at substantially regular angular intervals around the center axis of the stent.
In addition, in the stent 70 in this example, the first wavy strut 73 has a structure in which, except in both side portions, substantially the same waveform continues over a predetermined length. Specifically, the first wavy strut 73 has a structure in which, except in the vicinity of both end portions, substantially the same waveform, in other words, a wave of the same wavelength and the same amplitude, continues. In the case where the first wavy struts 73 have the same waveform throughout substantially the whole part thereof, the wavelength, though different depending on the outside diameter of the stent, is preferably 0.5 to 8.0 mm, and more particularly, preferably 2.0 to 4.0 mm, and the amplitude is preferably 0.1 to 10.0 mm, and more particularly, preferably 0.3 to 3.0 mm.
The second wavy struts 74 extend in an axial direction substantially parallel to the center axis of the stent. The second wavy struts 74 are arrayed in plurality in the circumferential direction of the stent, and each of the second wavy struts 74 is arranged between the first wavy struts. The number of the second wavy struts is preferably not less than two, and more particularly, preferably three to eight. Furthermore, the plurality of second wavy struts 74 are preferably arranged at substantially regular angular intervals around the center axis of the stent. In addition, the number of the second wavy struts 74 is the same as the number of the first wavy struts.
As above, in this stent 70, the second wavy strut 74 has a structure in which, except in both side portions, substantially the same waveform continues over a predetermined length. Specifically, the second wavy strut 74 has a structure in which, except in the vicinity of both end portions, substantially the same waveform, in other words, a wave of the same wavelength and the same amplitude, continues. In the case where the second wavy struts 74 have the same waveform throughout substantially the whole part thereof, the wavelength, though different depending on the outside diameter of the stent, is preferably 0.5 to 8.0 mm, and more particularly, preferably 2.0 to 4.0 mm, and the amplitude is preferably 0.1 to 10.0 mm, and more particularly, preferably 0.3 to 3.0 mm.
Furthermore, in this stent 70, the first wavy struts 73 and the second wavy struts 74 have substantially the same waveform. Specifically, in the stent 70, the first wavy strut 73 and the second wavy strut 74 have substantially the same wavelength and substantially the same amplitude; in addition, the second wavy struts 74 are shifted by about one half the wavelength in the axial direction of the stent, in relation to the first wavy struts 73.
Therefore, as shown in
In addition, in the stent in this example, the wavy struts 73 and 74 are all the same in length, except for both end sections. Therefore, when the stent is compressed in the radial direction, each of the struts approaches parallelism with the axial direction, and, since the struts are the same in length, the stent is reduced in diameter favorably, without the struts stiffening in the axial direction. Besides, in the stent in this example, the wavy struts 73 and 74 are, except at both ends thereof, arranged at regular angular intervals around the center axis of the stent. When the stent is compressed in the radial direction, therefore, the gaps between the struts are equally reduced, so that the stent is favorably contracted without mutual overlapping of the struts.
As shown in
The stent 70 in this example is provided with, at the distal portion thereof, bent sections 72 each formed by coupling distal portions of the first wavy strut 73 and the second wavy strut 74, and bent sections 76 each formed by coupling the distal portion of a linear section 63 connected to the first wavy strut 73 through a branching section 61 and the distal portion of a linear section 64 connected to the second wavy strut 74 through a branching section 62. The bent sections 72 and the bent sections 76 are provided alternately along the circumferential direction of the stent 70. In addition, a radiopaque marker 77 is mounted to each of the bent sections 76. The bent sections 76 provided with the radiopaque markers 77 are located on the stent, on a distal side relative to the bent sections 72.
In addition, the stent 70 is provided at the proximal portion thereof with bent sections 79 each formed by coupling proximal portions of the first wavy strut 73 and the second wavy strut 74, and with bent sections 78 each formed by coupling the proximal portion of a linear section 83 connected to the first wavy strut 73 through a branching section 81 and the proximal portion of a linear section 84 connected to the second wavy strut 74 through a branching section 82. The bent sections 79 and the bent sections 78 are provided alternately along the circumferential direction of the stent 70. In other words, in the stent 70, the bent sections 78 and the bent sections 79 form the proximal portion oriented to the proximal side of the sheath (stent-containing member). A radiopaque marker 77 is mounted to each of the bent sections 78. Incidentally, in this stent 70, the radiopaque markers 77 form a proximal inwardly protruding section 77a which will be described later. The bent sections 78 provided with the radiopaque markers 77 are located on the stent, on a proximal side relative to the bent sections 79. In addition, this stent 70 does not have a free end oriented to the proximal side of the stent, except for the bent sections 78 and 79. Therefore, at the time of moving the sheath toward the distal side relative to the inner tube body after a distal portion of the stent is partly exposed from the sheath, the absence of any free end (of the stent) extending toward the proximal side of the sheath (stent-containing member) ensures that the stent can again be contained into the sheath (stent-containing member) without being caught on the sheath. Further, in this stent 70, the linear sections 83 and 84 constituting the bent sections 78 at the proximal portion are axially longer than the linear sections 63 and 64 constituting the bent sections 76 at the distal portion of the stent. The stent 70 is inserted into a living body from the distal side (the bent section 76 side) thereof and is put indwelling in the living body.
In addition, the radiopaque marker 77 envelopes substantially the whole part or a part of the two frame portions constituting the bent section. The radiopaque marker 77 is a thin rectangular parallelopiped body, contains therein the two frame portions, and is depressed in the central portion thereof, to be thereby fixed to the two frame portions. The material forming the radiopaque marker can suitably be used either one (simple substance) or at least two (alloy) of the materials selected from the group consisting of iridium, platinum, gold, rhenium, tungsten, palladium, rhodium, tantalum, silver, ruthenium, and hafnium. The length of the marker is preferably 0.1 to 4.0 mm, and more particularly, preferably 0.3 to 1.0 mm. The material thickness of the marker is preferably 0.01 to 0.30 mm, and more particularly, preferably 0.03 to 0.10 mm.
As shown in
As described above, in the stent delivery system according to the embodiments disclosed herein, the stent includes a distal portion and a proximal portion oriented respectively to the distal side and the proximal side of the stent-containing tube body. The stent does not, except in the proximal section thereof, have a substantially bent free end protruding to the proximal side. Therefore, a locked state of the stent which might arise from being caught on the distal contact section and the proximal contact section is prevented from occurring, and a favorable stent-discharging operation is ensured. Further, even after the stent is partly exposed from the stent-containing tube body, the stent can again be contained into the stent-containing tube body, owing to the engagement between the distal contact section of the inner tube body and the proximal inwardly protruding section of the stent, and the stent disposing position can be corrected. Accordingly, the stent can be assuredly disposed in a target part. In addition, the operation of containing the stent into the stent-containing tube body is easy to carry out.
The configurations of the above-described embodiments thus provide a stent delivery system using a self-expandable stent, wherein a favorable stent-discharging operation is ensured, the stent can again be contained into the delivery system even after the stent is exposed from the delivery system to some extent, and it is easy to contain the stent into a stent-containing tube body.
The detailed description above describes features and aspects of examples of embodiments of a stent delivery system. The present invention is not limited, however, to the precise embodiments and variations described. Various changes, modifications and equivalents could be effected by one skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims. It is expressly intended that all such changes, modifications and equivalents which fall within the scope of the claims are embraced by the claims.
Number | Date | Country | Kind |
---|---|---|---|
2009-298159 | Dec 2009 | JP | national |
This application is a continuation of International Application No. PCT/JP2010/073149 filed on Dec. 22, 2010, which claims priority to Japanese Patent Application JP2009-298159 filed in Japan on Dec. 28, 2009, the entire content of both of which are hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/JP2010/073149 | Dec 2010 | US |
Child | 13534567 | US |